Meeting
2022 ASCO Annual Meeting
Molecular characterization of the tumor microenvironment in chromophobe renal cell carcinoma (ChRCC) and related oncocytic neoplasms.
Authors
Chris Labaki
Dana Farber Cancer Institute, Boston, MA
Chris Labaki , Long Zhang , Yue Hou , Kevin Bi , Charbel Hobeika , Ziad Bakouny , Sabrina Yvonne Camp , Carmen Priolo , Damir Khabibullin , Nicholas Schindler , Michel Alchoueiry , Thomas Denize , Renee Maria Saliby , Sayed Matar , Sabina Signoretti , Eliezer Mendel Van Allen , Sachet A. Shukla , David A. Braun , Elizabeth Henske , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4549)
DOI
10.1200/JCO.2022.40.16_suppl.4549
Abstract #
4549
Poster Bd #
40
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Using the tumor microenvironment to identify predictors of immunotoxicity to checkpoint inhibitors.
First Author: William Alexander
Poster
2024 ASCO Annual Meeting
SB221: A proof-of-concept study to assess the combination of SON-1010 (IL12-FHAB) and atezolizumab in patients with platinum-resistant ovarian cancer.
First Author: Sant P. Chawla
Poster
2024 ASCO Annual Meeting
Retrospective analysis of change in frequency of STK11 mutation in lung adenocarcinomas over a 10-year period.
First Author: Deevyashali Parekh
Poster
2024 ASCO Genitourinary Cancers Symposium
Fluorescence in situ hybridization utility in the care management of renal cell carcinoma (prospective study, 30 cases).
First Author: Rafik BEN Tayeb